コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e, we identify 15 SH2B1 variants in severely obese children.
2 r the direction of evidence-based therapy in obese children.
3 ence of metabolic syndrome in overweight and obese children.
4 ring childhood, especially in overweight and obese children.
5 Energy expended in activity was lower in the obese children.
6 Obese parents are more likely to have obese children.
7 hemostatic variables in a biethnic group of obese children.
8 e in regulating plasma hemostatic factors in obese children.
9 arkers, and retinal microvascular changes in obese children.
10 ut microbial composition between healthy and obese children.
11 be considered in the clinical management of obese children.
12 inflammation in a cohort of African American obese children.
13 appropriate weight-based dosing strategy for obese children.
14 rnatives more reinforcing than do overweight/obese children.
15 and dicarboxylated fatty acids were seen in obese children.
16 rylcarnitine, were significantly elevated in obese children.
17 creased steroid derivatives may be unique to obese children.
18 NAFLD was identified in 24% of the recruited obese children.
19 l NO(2) levels may improve asthma health for obese children.
20 isease (NAFLD) are frequently encountered in obese children.
21 increase physical activity in overweight and obese children.
22 ficantly longer lengths of hospital stay for obese children.
23 bserved only in adults, is also occurring in obese children.
24 allele would influence the risk of NAFLD in obese children.
25 thood between MHO children and nonoverweight/obese children.
27 TC varies between 4.8% and 12.3% (higher in obese children [12.3%] and at the ages when TC naturally
28 lerance was detected in 25 percent of the 55 obese children (4 to 10 years of age) and 21 percent of
31 d high-sensitivity C-reactive protein in 108 obese children, 54 with (HFF >/=5%) and 54 without NAFLD
32 geal reflux scores were higher in overweight/obese children (9.6 vs 23.2; P = .003) and appear to med
36 ontrolled trials conducted in overweight and obese children aged 18 years or younger, comparing dieta
40 < 1 x 10(-5)) in an additional 971 severely obese children and 1,990 controls identified 4 new loci
42 his cross-sectional study, 45 overweight and obese children and 46 age- and sex-matched healthy indiv
44 s58542926 SNP in a multiethnic cohort of 957 obese children and adolescents (42% Caucasians, 28% Afri
48 pared with healthy children and adolescents, obese children and adolescents reported significantly (P
50 e risk for impaired health-related QOL among obese children and adolescents to target interventions t
53 OL total score (mean [SD], 53.8 [13.3]) than obese children and adolescents without obstructive sleep
54 ence of the metabolic syndrome is high among obese children and adolescents, and it increases with wo
57 omains (mean [SD] total score, 67 [16.3] for obese children and adolescents; 83 [14.8] for healthy ch
63 would be useful in diagnosing overweight and obese children and in developing effective strategies fo
65 h and without physical training on leptin in obese children and to explore the determinants of leptin
66 ectional analysis of data from overweight or obese children and young adults 3 to 19 years of age who
67 al weight, 10.8% of overweight, and 26.9% of obese children) and age (8.9% of 9- to 11-year olds and
68 e screening and assessment of overweight and obese children, and those with an elevated WHtR should u
69 oxidative stress and inflammation evident in obese children are associated with distinct metabolomic
72 besity, and altered MAIT cell frequencies in obese children are positively associated with insulin re
76 Steroid derivatives were markedly higher in obese children as were markers of inflammation and oxida
77 TDEE and RMR were significantly higher in obese children, as a result of their greater fat-free ma
78 cardiovascular disease does not manifest in obese children, assessment of the subclinical markers of
79 rly understood interplay might be present in obese children, assessment of the vasculature directly,
81 ences have consistently been demonstrated in obese children, but the time course and development of a
82 patic steatosis in a series of overweight or obese children by using the imperfect gold standard meth
83 on of vitamin D deficiency in overweight and obese children by vitamin D3 supplementation with 1000 o
84 escriptions of echocardiographic findings in obese children, children engaged in athletic activities,
86 wing 13 years with normal weight status, and obese children could expect to live 9.8 years with obese
87 and a childhood cancer has been identified: obese children diagnosed with high-risk acute lymphoblas
89 caregivers (PACs) as "agents of change" for obese children, evaluating the strength of evidence that
92 pharmacokinetic alterations were observed in obese children for 65% (11 of 17) of the studied drugs.
94 rown-like structures, was increased in AT of obese children from 6 years on and was associated with h
95 study, we genetically screened 225 severely obese children from consanguineous Pakistani families th
100 h and without OSA at initial study; however, obese children had significantly higher insulin (106.1 +
103 enditure has shown clearly that, as a group, obese children have higher energy expenditures than do t
104 esearch purporting to show that, as a group, obese children have lower energy intakes than do lean ch
105 ene variants by exome sequencing of severely obese children, including those from consanguineous fami
106 ciation cannot rule out the possibility that obese children ingest food with higher BPA content or ha
111 etabolic flexibility in fuel use observed in obese children may occur through the activation of alter
113 ol (Fisher exact test; P = .003); overweight/obese children more often reported shortness of breath (
117 the investigation and treatment of asthma in obese children, particularly in comparison with current
120 Global metabolomic profiling in nonobese and obese children replicates the increased BCAA and acylcar
121 V1 1.87 vs 0.45 mg/mL; P < .012), overweight/obese children reported more than thrice frequent rescue
123 es (RR = 1.08) complied more, but overweight/obese children (RR = 0.81), earlier maturing children (R
127 is linked to increased inflammation in AT in obese children, thereby providing evidence that obesity-
129 g energy expenditure, it has been shown that obese children underreport intake significantly more tha
132 rmine, in vitamin D-deficient overweight and obese children, whether supplementation with vitamin D3
134 .7 mIU per liter) than those in 340 severely obese children who did not have GNAS mutations (3.9 2.6
137 region that includes SIM1, were reported in obese children with a Prader-Willi-like syndrome; howeve
139 is associated with increased morbidity among obese children with asthma and may partly explain their
140 elated asthma.Measurements and Main Results: Obese children with asthma had more memory and fewer nai
142 compared the CD4(+) T-cell transcriptome in obese children with asthma with that in normal-weight ch
144 s and methylation quantitative trait loci in obese children with asthma, independent of Th-cell subty
145 sociated with pulmonary function deficits in obese children with asthma.Conclusions: We found enrichm
149 HEAS (OR: 2.16; 95% CI: 1.51, 3.09); at 7 y, obese children with high DHEAS were fatter and more cent
154 ed for age, gender, and pubertal status, and obese children with NAFLD were matched for body mass ind
156 growth from 0 to 7 y of age in nonobese and obese children with normal and high DHEAS (>/=75th perce
157 7 +/- 0.6 nmol/L; p = 0.005) and a trend for obese children with persisting OSA to have elevated insu
158 s with insulin resistance (pre-diabetes) and obese children with type 2 diabetes, years before overt